Cytori shares slammed as safety concerns halt stem cell trials – FierceBiotech

Cytori shares slammed as safety concerns halt stem cell trialsFierceBiotechCytori Therapeutics ($CYTX) hit the brakes on a pair of clinical trials to find out why three patients in the study suffered from "cerebrovascular" events after they were treated with the biotech's experimental stem cell treatment. The San Diego-based ...Cytori halts stem cell study due to adverse eventsBusinessweekall 27 news articles
http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHpc7wZbEZgh3HnjFZg0V_aNTAK9A&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52778577323686&ei=oFXiU9CABeq4mQLb84DAAg&url=http://www.fiercebiotech.com/story/cytori-shares-slammed-safety-concerns-halt-stem-cell-trials/2014-08-06&utm_source=rss&utm_medium=rss&utm_campaign=cytori-shares-slammed-as-safety-concerns-halt-stem-cell-trials-fiercebiotech